Navigation Links
Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
Date:11/18/2011

LOS ANGELES, Nov. 18, 2011 /PRNewswire/ -- Qmed.com, the world's only 100% qualified medical device supplier directory, search engine, and central industry resource, today announced a new powerful business intelligence tool is now live on the Qmed site as part of its continuing commitment to provide users with additional resources.

(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

"I am very pleased to announce that this new regulatory and product development tool is now available to all Qmed users," stated Tim Simone, Qmed Brand Director.  "This is just one example of the many ways we continue to enhance Qmed and provide users with the most relevant, time-saving, and cost-effective tools. Qmed is dedicated to providing the medical device industry with resources and information that assist in the development of life-saving medical technologies."

This new resource listed under Regulatory Tool on the Qmed Resources tab, provides Qmed users exclusive access to proprietary e-Zassi software. Part of the tool, free only to Qmed users, is powered by a database of information on classified medical devices. After the user enters information regarding their current project, this tool then searches and provides potential predicate codes and pathway for medical technology in Cardiovascular, Orthopedic, Gastroenterology & Urology, General/Plastic Surgery and Radiological devices.

A full report is also available to Qmed users at a greatly discounted rate exclusively only on Qmed.com. This extensive version calculates the future development and commercialization milestones of a new medical technology. It also provides insight into the pivotal product development hurdles that affect medical device product decision making. The software does not utilize any confidential information, allowing the information to be shared with business partners and vendors, regardless of patent status.

Learn more and access the new resources on Qmed here.

About Qmed

Qmed is the world's ONLY 100% qualified medical device supplier directory, search engine and industry resource, created exclusively for OEMs actively researching and sourcing qualified suppliers, products, and services during the product design cycle. Powered by advanced keyword search and embedded with relevant supplier and industry content, rich media, and RFP opportunities, Qmed is the critical resource used to connect medical device OEMs with qualified suppliers. From medical contract manufacturers to stock component suppliers and medical device consultancies, Qmed's powerful search tool, directory, and white paper library serves only relevant, editorially screened supplier listings and resources to provide the most efficient supplier-sourcing experience for medical device OEMs. Qualified suppliers are determined by verification of the following criteria: currently working with medical device OEMs, exhibit at medical device industry trade shows, are GMP compliant, ISO 9000, and/or FDA–registered.

About UBM Canon

UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.

About e-Zassi

e-Zassi is the first Innovation Management (IM) software platform designed to address the needs of the patent centric medical device industry. The platform delivers a standardized approach to the submission, capture, decision support and sharing of ideas, in a non-confidential assessment format that minimizes intellectual property disclosure risks. The suite of web-based software solutions delivers critical business intelligence on product development and commercialization burdens associated with a new med-tech application. The outputs are generated in real time and immediately available to the user driving better decision making, due diligence and increased business development efficiency.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS
2. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
3. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
9. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
10. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
11. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017   The Accreditation Council ... medical affairs in the pharmaceutical industry has appointed ... of a newly formed scientific advisory board. Dr. ... form the first ever medical affairs think tank ... information about the ACMA, please visit  www.medicalaffairsspecialist.org .  ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global Idiopathic ... ... strong with a total of 97 drug candidates. Pharma giant such as ... in the development of the IPF therapeutics. The IPF pipeline comprised of ... are in Phase II stage, 12 are in Phase I stage, 39 ...
(Date:3/24/2017)... -- Today Stock-Callers.com have issued research reports on ... (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. (NYSE: ... These companies are part of the Healthcare sector, which gave ... rd , 2017, with the NYSE Health Care Index declining ... in the S&P 500 were down about 0.4% as a ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
(Date:3/24/2017)... ... 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased to ... Road. The clinic is the group’s 7th location in San Antonio and 23rd in ... will provide care from the clinic, which opened March 22, 2017. , ...
(Date:3/24/2017)... Pittsburgh, PA (PRWEB) , ... March 24, 2017 ... ... the Oncology Nursing Society (ONS) wanted to create a communications platform that positions ... realize this goal, Elliance and ONS reinvented their online publication as an always-on, ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... ( http://www.hygieacare.com ) announced their partnership to prep patients for colonoscopy at the ... Endoscopy Centers in 87th Ave., Miami, FL. , The HyGIeaCare® Prep, ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
Breaking Medicine News(10 mins):